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Summary.-An apparently unique circulating common oncofoetal protein has been
identified in rat small-bowel, colonic and pancreatic adenocarcinomas. The tumours
were induced by ionizing radiation (small bowel), an alkyl hydrocarbon, 1,2-dimeth-
ylhydrazine (colon) and a polyaromatic hydrocarbon, 7,12-dimethylbenz[a]anthra-
cene (pancreas). The oncofoetal protein was identified by the use of specific xenogenic
antitumour rabbit sera generated to the X-ray-induced neoplasm. In addition, the
foetal protein was also found always to occur in the liver and lungs of those animals
bearing the chemically induced tumours as well as in their serum. These results
suggest the existence of a close relationship at the molecular level in the tumorigenic
processes, even though induction is by apparently different mechanisms, for cancers
arising in tissue or common embryonic origin,
CELLULAR DIFFERENTATION anid ueo-
plasia have been linked by the discovery
in adult individuals of foetal specific
antigens and foetal-type isoenzymes asso-
ciated with many spontaneously occurring
human (Gelder et al., 1978) and animal
(Price, 1974) cancer cells. Studies on
the occurrence of similar tumour-associa-
ted foetal antigens (TAFA) have suggested
that one of the physical properties that
cancer cells have in common is the exist-
ence of such foetal products, though
the tumours may be indicated by entirely
different agents. One such study has
shown that a common murine TAFA
occurring in 9-19-day embryos could
be detected in RNA virus-induced tumours
chemical, as well as X-irradiation-in-
duced, and spontaneous mouse tumours
(Stonehill & Bendich, 1970). A similar
study demonstrated common TAFA in
methylcholanthrene-inducedfibrosarcomas
and Maloney sarcoma virus osteosarcoma
(Evans et al., 1979).
Studies of rat intestinal carcinomas
in culture that had been induced in vivo
by 1,2-dimethylhydrazine (DMH) and
N-methyl-N'-nitro-N-nitroso-guanidine
(MNNG) have been shown to contain a
common carcinofoetal-like antigen located
in the membrane of the cells (Martin
et al., 1975). In addition tofoetal specificity
these antigens were also found to have
tissue specificity, their presence not being
demonstrable on non-intestinal tumour
cells (hepatoma, glioma, neurinoma). Lym-
phocyte microcytotoxicity investigations
also suggested the existence of such
tumour-associated antigens in DMH- and
MMNG-induced rat colon tumours (Steele
& Sjogren, 1974; Steele et al., 1975a).
In attempts to characterize such antigens
of the chemically induced rat colonic
carcinomas further, embryonic specificity
was identified, since lymphocytes from
the tumour-bearing rats were found to be
cytotoxic to foetal-colon target cells,
but not to other foetal cells (Steele &
Sjogren, 1l974; Steele et al., 1975b).
However, investigations involving deter-
mination of specificity for the DMH-
and N-methyl-n-nitrosourethane-induced
murine colon tumours indicated by trans-
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reacting tumour-specific transplantation
antigens were present (Belnap et al.,
1979).
Our own studies have demonstrated
the presence of common oncofoetal pro-
tein(s) existing in X-ray-induced rat
small-bowel adenocarcinomas (Stevens et
al., 1975, 1976). Immunoglobulins were
identified, associated with the X-ray-
induced tumour, which were able to
bind the oncofoetal protein, specifically
thus classifying it as a foetal antigen
in its ability to evoke a host immune
response (Stevens et al., 1978a). The
present studies were undertaken to deter-
mine whether such TAFA as found
with the X-ray-inducedlesionweresimilar-
ly associated with chemically induced rat
colonic and pancreatic adenocarcinoma
cells.
MATERIALS AND METHODS
Gastrointestinal cancer was induced in
adult 200-250 g male rats by the following
3 procedures:
(i) Small bowel adenocarcinomas were
induced in the Holtzman rat (Holtzman
Co., Madison, Wisc.) by exposure of only
the jejunum and ileum to 20 Gy of
X-rays (radiation factors were 250 kVp, 30
mamp, 0-25 mm Cu and 1D0 mm Al filtration)
at a rate of 2 Gy/min, as determined by a
Victoreen R-meter. Visible lesions developed
in 4-6 months in 25% of the animals
irradiated (Coop et al., 1974)
(ii) Colonic tumours were induced in the
Holtzman rat through weekly s.c. injections
of DMH (Aldrich Chemical Co., Milwaukee,
Wisc.) at a dosage of 20 mg/kg body weight
fora20-week period (Bandara etal., 1975). The
DMH was prepared before each injection by
dissolution in0-9% isotonic saline and neutra-
lization to a pH of 6-5 with IM NaOH
(iii) Pancreatic adenocarcinomas wereindu-
ced in Fisher F344 (Charles River Breeding
Lab., Wilmington, Mass.) bytheimplantation
of 7-12 dimethylbenz[a]anthracene (DMBA)
intothehead ofthe organ. Theprocedure,with
a slight modification ofthat originally descri-
bed by Dissin et al., (1975), consisted of
dissolving the crystalline DMBA (100 mg) in
melted white beeswax (1 g); the hot mixture
was then poured immediately on to cold
aluminium foil. After solidification, a thin
cake of the DMBA-beeswax was sectioned
into slices, each containing 3 mg of the
chemical. The slice was then implanted into
the "head" of the pancreas by suturing
5-0 silk through the slice and attaching it
directly to the tissue, which was then covered
with surrounding pancreatic tissue (Stevens
et al., 1978b). Age-matched control animals
were treated identically, with the implanta-
tion of an approximately equal amount of
beeswax which did not contain DMBA.
Histological examinations indicated that the
tumours induced by the DMBA-beeswax
implantation were carcinomas of exocrine
origin, with a ductule-like structure, and
preliminary study of surrounding neoplastic
tissues showed various degrees of damage to
the acinar cells.
Micro-double diffusions were carried out in
1% Noble agar (Ouchterlony, 1962) and
immunoelectrophoresis was performed in
0-05N veronal buffered (pH 8-6 r/2=0d1) 1%
Noble agar(Hirschfeld, 1960). Theantitumour
serum was prepared in male New Zealand
white rabbits against the TAFA isolated from
the cellular membranes of the X-ray-induced
small-bowl adenocarcinoma. The procedure
for isolating the TAFA followed the methods
outlined for isolating soluble melanoma
tumour-associated antigens (Roth et al.,
1976). This involved a hypertonic salt ex-
traction which is known effectively to solu-
bilize both histocompatibility and tumour
antigens, and consisted of the follow steps:
Fresh tumour tissue was removed and all
necrotic and normal-appearing surrounding
tissue was discarded. Single cells were pre-
pared by finely mincing the tumour and pass-
ing it through a fine-mesh screen. The cells
were suspended in a solution of stirred 3M
KC1 in phospate-buffered saline (PBS) (pH
7.4) for 18 h at 4°C. The mixture was sedi-
mented by centrifugation at 20,000 g for 30
min the pellet discarded and the supernatant
recentrifuged at 110,000 g for 90 min. The
resulting supernatant was dialyzed against
500 volumes of PBS (pH 7 4) with 3 changes
over 18 h, and any precipitated proteins were
removed by centrifugation at 110,000 g for
90 min. The soluble proteins were then used
to immunize the adult male rabbits by intra-
dermal injections with a total of500 ,ug ofthe
proteins emulsified in Freund's complete
adjuvant (Difco) into proximal hind limbs
and s.c. into one right hind toe pad
(0-05 ml) so that each animal received a
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total of 2 ml emulsion. Two weeks later, the
animals were rechallenged s.c. with 300 pg
of the immunogen in Freund's incomplete
adjuvant at 5 sites, each animal received a
total of 1 ml. The isolated antiserum was
stored at 20°C with 0-0001% merthiolate as a
preservative. Serum absorptions were per-
formed with lyophilized homogenates of
normal rat liver, lung kidney, spleen, small
and large intestine by adding each to the
rabbit serum (19 mg/ml), stirring for 60 min
at 37°C, and centrifuging at 800 g for 10 mim
to remove any insoluble material. Antibody
titre was established by the percentage bind-
ing ofthe radioiodinated [125I] TAFA isolated
and partiallypurified from theX-ray-induced
rat small-bowel cancer (Stevens et al., 1976).
Tissue homogenates for the microdiffusion
studies were prepared by dissecting away any
accompanying fat, connective tissue and
necrotic tissues from the tumours, and the
latter were then washed x 5 with fresh 50mM
PBS (pH 7.4) and minced into 1-3 mm
fragments. These were homogenized with a
Polytron (Brinkman Instruments, Inc., West-
bury, New York) in PBS and centrifuged at
3000 g to precipitate anyremaining wholecells
and large fragments. The protein content of
each tissue extract was determined by the
Lowry method using Fraction V bovine serum
albumin (Sigma Chemical Co., St Louis, Mo.)
as standard.
RESULTS
In our earlier studies, we were able to
identify an apparently unique TAFA
associated with X-ray-induced small-
bowel adenocarcinoma in the rat (Stevens
et al., 1975, 1976). One of the important
characteristics found for this TAFA was
its foetal nature, as a similar protein
was identified in the intestinal tissue
of 17-19-day-old rat embryos. Its
structure was that of a glycoprotein
(though specific sugar analysis remains
to be carried out) with its immuno-
reactivity unaffected by enzymes such
as nucleases and neuraminidase, while
being destroyed by endo- and exopeptides.
Detergentsolubilizationwith sodium dode-
cylsulphate followed by molecular-exclu-
sion chromatography revealed that the
substance was apparently not a single
protein but had at least 6 different
molecular weights, all having common
immunoreactivity around 200,000 dalton
to the antiserum. It migrated under
electrophoretic conditions as a / globulin,
further being soluble in 100% ammonium
sulphate and heat-stable (100°C/20 min).
Its immunoreactivity was labile under
acidic conditions (0-1N HCI) but base-
stable (0.9N NaOH) at room temperature.
While rat specificity was niot found, the
TAFA existing in tumours of Holtzman
LewisBrown-Norway, Buffalo andFischer
rats, it could not be detected in any other
tissue (e.g. liver, kidney, lung, large
bowel and spleen) of the tumour-bearing
rats. However, it was released intact
into the circulatory system of these
animals. Its antigenicity in the host
has been presumed because specific IgG
for the protein has been identified in the
tumour-bearing rat (Stevens et al., 1978a).
Extensive studies have been undertaken
in an attempt to detect the TAFA in
normal animals, with no success. Sera
and faeces have been concentrated more
than 100-fold with the immunoprecipitin,
immunofluoresence andradioimmunoassay
in urine, and tissue extracts from un-
exposed rats. Procedures which were
used to detect its presence in the tumours
were all negative for the presence of the
TAFA.
Our present findings now indicate
that the protein also exists in rats which
have chemically induced pancreas and
colonic adenocarcinomas. We have identi-
fied this oncofoetal protein in tumour
tissue of every rat with DMH-induced
colonic (12 animals) or DMBA-induced
pancreatic (8animals) cancer.Thefollowing
results are representative ofthese observa-
tions. Ouchterlony analysis of the neo-
plasms using the xenogenic antitumour
rabbit serum generated against the X-ray-
induced cancer revealed the presence of a
common protein (Fig. 1). Further confir-
mation for the similarity was suggested
fromtheimmuno-electrophoretic studiesof
the cellular homogenates ofthe neoplasms.
Both the DMH-induced colonic (Fig. 2)
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FIG. 1. Ouchterlony analysis of gastrointestinal lesion homogenates prepared from whole cells for the
existence of a common oncofoetal protein. Normal:rat small-bowel tissue (53 ,tg); X-ray: small-
boweladenocarcinoma (43jug); DMBApancreatic adenocarcinoma (48 jHg); DMH:colonicadeno-
carcinoma (51 Zg) protein. AB: absorbed rabbit antiserum generated against the X-ray-induced
rat small-bowel cancer at a titre of 1:5.
FIG. 2.-Immunoelectrophoretic analysis for a common oncofoetal protein in DMH- (colonic, 51 yg)
and X-ray- (small bowel, 43 ,ug) induced adenocarcinoma. AS: absorbed rabbit antiserum genera-
ted against the X-ray-induced rat small-bowel cancer at a titre of 1: 5.
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FIG. 3.-Immunoelectrophoretic analysis for a common oncofoetal protein in X-ray- (small bowel,
43 jig) and DMBA- (pancreatic 48 ,ug) induced adenocarcinomas. AS: absorbed rabbit antiserum
generated against the X-ray-induced rat small-bowel cancer at a titre of 1: 5.
Fia. 4. Ouchterlony analysis for the presence of a common oncofoetal protein in the organs of rats
with DMH-induced colonic cancer. Precipitin wells (quantity of protein in parentheses) were as
follows: Normal colon (52 jig) consisted of tissue obtained from unexposed rats. Lung (33 ,ug) tissue
from animals with DMH-induced colonic tumours. X-ray (43 jig) wasfrom small-bowel adenocarci-
nomas induced by exposure to ionizing radiation. Liver (38 p,g) tissue from rats with DMH-induced
colonic cancer: DMH (51 ig) colonic lesions induced by the chemical. Normal liver (54 jig) tissue
obtained from unexposed animals. Centre: the antiserum at a titre of 1: 5.R. H. STEVENS, D. A. COLE AND H. F. CHENG
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FIG. 5. Ouchterlony analysis for the presence of a common oncofoetal protein in organs of rats with
DMBA-induced pancreatic cancer. Normal: pancreatic tissue from control rats with only beeswax
pellet implant (56 ,tg); X-ray: small-bowel adenocarcinoma (43 ,ug); Panc: DMBA-induced
pancreatic adenocarcinoma (48 ,g) Organs from rats with the DMBA pancreatic cancer Lung (41
,ug); Liver (47 pg); Spleen (39 ,ug) AB: absorbed rabbit antiserum generated gainst the X-ray-in-
(luced rat small-bowel cancer at a titre of 1 :5.
and DMBA-induced pancreatic (Fig. 3)
adenocarcinomas contained the oncofoetal
protein in the X-ray-induced small-bowel
neoplasm, when the migration studies
were run against the antiserum to the
X-ray-induced tumour.
Other studies involving DMH and
DMBA tumorigenesis have shown these
chemicals lack organ specificity. For
example, DMH has been shown to induce
small-bowel adenocarcinoma (Ward, 1974;
Dissin et al., 1975), while the aryl hydro-
carbon hydroxylase enzymes necessary
for activating the procarcinogen DMBA
have been identified in monkey, hamster
and rat small intestine (Nebert & Gelboin,
1969). We investigated the possible exist-
ence of the oncofoetal protein in other
organs of the rats bearing the chemically
inducedneoplasms. Theprotein has always
been positively identified by the Ouchter-
lony technique in the liver and lungs of
those animals bearing chemically induced
colonic (Fig. 4) and pancreatic (Fig. 5)
tumours. Many of the kidneys, spleens,
and apparently non-involved intestinal
tissues also had detectable levels of this
protein. About 10-15% of the rats
given long-term DMH developed small-
bowel adenocarcinomas as well as colonic
tumours. Our studies of these small-
intestinal neoplasms always indicated
the presence of the foetal protein.
Previously, we found the oncofoetal
protein in the circulatory system of
rats having X-ray-induced small-bowel
adenocarcinomas (Stevens et al., 1975,
1976). Its presence in the blood might be
one reason for finding the foetal protein
in the liver and lungs of animals bearing
the DMH-induced colonic and DMBA-
induced pancreatic cancers. As in the
previous observations, we identified the
oncofoetal protein in the serum of rats
with either the DMH- or DMBA-induced
tumours (Table). In addition, the fluid
which was encapsulated by the large
DMBA-induced pancreatic lesions was
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TABLE.-Presence of the oncofoetal protein
inorgans of rats with X-ray or chemnically
induced tumours
Organ
Small bowel
Colon
Pancreas
Stomach
Liver
Lung
Spleen
Kidney
Serum
Bile
Cancer*
Small bowel Colon Pancreas
(X-ray) (DMH) (DMBA)
+
a Ouchterlony analysis was used to identify the
common oncofoetal protein, (+) indicating positive
identification in the organs from at least 5 tumour-
bearing animals and (-) representing either
variable or no detection of the protein. Cellular
homogenate concentrations for tissues found to be
negative were varied over a range up to 150 ,ug
protein and antiserum titre of 1 :5.
found to contain a very high content of
this protein. The remaining composition
of this fluid has yet to be investigated,
but in addition to the foetal protein it
contained numerous lymphoid cells. So
whether this fluid primarily represents
pancreatic juice leaked from the cells
owing to the development of the lesion,
or simply an irritative response to the
presence of the chemical remains to be
determined. The control animals, which
had only beeswax implanted in the
pancreas, never contained such a fluid
reservoir, so its formation cannot be
attributed to either the surgery or the
beeswax. For those tissues which were
negative, the cellular homogenate concen-
trations and antiserum titre were varied
to ensure that the appropriate concentra-
tions were being utilized. In addition,
antiserum absorptions (10 mg protein/ml)
with both the positive and negative
tissues were carried out. In all the tests,
serum absorptions with tissues reported as
positive removed the immunoprecipitin
activity, and those reported as negative
appeared to have no effect.
A number of studies attempted to
determine the tumour specificity of this
foetal protein. Again, although our results
56
are qualitative, we only detected this
oncofoetal protein in tissues or culture
cells obtained from animals with digestive-
tissue lesions.
DISCUSSION
Greenstein, as early as 1945, recognized
that a feature of many cancer cells was
their foetal characteristic, and stated
"tumours tend to converge to common
enzymatic patterns that in certain cases
resemble those offetal tissues" (Greenstein
1954). Our present findings suggest that
tumours induced in endodermally derived
tissue (small bowel, colon and pancreas)
produce detectable levels of a common
foetal protein. It is important to empha-
size that the induction procedures are
by apparently different mechanisms, con-
sistingofionizingradiation, analdylhydro-
carbon (DMH) and a polyaromatic hydro-
carbon (DMBA). This would suggest a
close relationship at the molecular level
between the development of tumours
derived from the same embryonic tissue
by cellular differentiation. Recently, Uriel
has very cleverly examined and discussed
thevariousobservations offoetalcharacter-
istics in cancer cells, and has noted that
one major question is whether such
tumourswithembryonicpropertiesdevelop
from differentiation of a tissue reserve
of stem cells, or by a process of retro-
differentiation (Uriel, 1976). He has noted
that the presence of such a reserve of
stem cells has not been demonstrated
in static or expanding cell populations,
whereas in contrast, retrodifferentiation
has been revealed in adult hepatocytes.
Although our findings do not aid in
distinguishing which process may actually
occur, theyare importantindemonstrating
that different forms of initiation in
different adult tissues that result in
cancer may lead to a common phenotypic
expression as noted by the detectable
levels of the oncofoetal protein.
While it is not yet clear why tumours
arising from tissues of common embryonic
origin develop similar foetal proteins,
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one suggested possibility is that they aid
the cancer cell in its avoidance of host
immune surveillance (Alexander, 1974).
Although at present we do not know
what role these proteins might play in
antitumourimmunity, wehave established
in previous studies of the X-ray-induced
neoplasm that there are both blocking
factors to antitumour cell-mediated im-
munity (among which is foetal protein)
and specific immunoglobulins (JgG) to
the protein (Stevens et al., 1978a). It
must also be considered that, like cx-
foetoprotein and human carcinoembryonic
antigen, this oncofoetal protein may
be a normal cell component which is
simply increased in quantity during tumo-
rigenesis. These questions can only be
answered when a quantitative assay for
oncofoetal protein has been developed.
However, in terms of specificity, our
results do suggest that the foetal protein
exists primarilyorexclusively withanimals
having endodermally derived digestive
tumours, as we were unable to identify
its presence in rats with spontaneous
mammary tumours (ectodermal origin)
and asbestos-induced mesotheliomas (mes-
odermal origin). Nor did nonspecific injury
trigger its synthesis, within the failure
to detect the protein in the remaining
tissue upon a 70% small-bowel resection,
even though this procedure produced
maximum crypt-cell proliferation (Hanson
et al., 1977). Other investigators have
shown that the foetal proteins of DMH-
induced neoplasms may serve as weak
tumour-rejection antigens (Steele &
Sjogren, 1977) but whether the presently
identified proteins have such a function is
unknown.
In summary, the use of antisera genera-
ted to X-ray-induced rat small-bowel
adenocarcinoma allowed the identification
of an apparently unique circulating onco-
foetal protein in the radiation-induced
neoplasm as well as in chemically induced
pancreatic and colonic cancer. This is
apparently a general phenomenon, as we
have studied over 100 rats with radiation-
induced neoplasms, and now 12 with the
DMH-induced colonic and 8 with DMBA-
induced pancreatic adenocarcinomas.
While other studies of carcinoembryonic
proteins, such as those carried out on
o-foetoprotein (Kroes et al., 1975) have
shown an increase on exposure to chemical
carcinogens, the present results are the
first to demonstrate that apparently the
carcinogen type is unimportant, provided
the target is digestive tissue. The role of
foetal proteins in tumorigenesis is un-
known, but studies are being presently
initiated to determine what influence
the oncofoetal protein identified in these
studies may have upon antitumour cell-
mediated immunityand to develop quanti-
tative methods of comparisons.
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